Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

344

HTML

2719

Figures (1-4)

190

Tables (1-2)

184

Sum=3437

Apr 21, 2009 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Apr 21, 2009; 15(15): 1843-1848
Published online Apr 21, 2009. doi: 10.3748/wjg.15.1843

Table 1 Patients’ demographic characteristics and etiology of liver cirrhosis n (%)

	Patients
Patients number	117
Gender
Male	81 (69.2)
Female	36 (30.8)
Age (yr)
mean ± SD	69 ± 7.8
Range	43-85
Causes of cirrhosis
HBV (hepatitis B)	9 (7.7)
HBV and NAFLD	5 (4.3)
HBV and alcohol abuse	1 (0.09)
HCV (hepatitis C)	59 (50.4)
HCV and NAFLD	16 (13.7)
HCV and alcohol abuse	10 (8.5)
Alcohol abuse	8 (6.8)
Alcohol abuse and overweight	8 (6.8)
Sarcoidosis	1 (0.09)

NAFLD: Non-alcoholic fatty liver disease.

Citation: Sacco R, Bertini M, Petruzzi P, Bertoni M, Bargellini I, Bresci G, Federici G, Gambardella L, Metrangolo S, Parisi G, Romano A, Scaramuzzino A, Tumino E, Silvestri A, Altomare E, Vignali C, Capria A. Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study. World J Gastroenterol 2009; 15(15): 1843-1848
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1843.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1843